moa

Proxalutamide 是具有口服活性的雄激素受体的拮抗剂。它可研究前列腺癌和COVID-19。

MOA-stilbene, also known as 3-Methoxy-2-(2-styrylphenyl)propenic acid methyl ester, is a fluorescence inhibitor. MOA-stilbene is a new tool for investigation of the reactions of the chloroplast cytochrome bf complex. MOA-stilbene is known to be a specific inhibitor of the Qo site of mammalian cytochrome bc 1 complex.

Methylnaltrexone bromide (MOA-728) 是纳曲酮的四元衍生物，是可口服的外周作用 μ 阿片拮抗剂。它穿越血脑屏障的能力有限，可在胃肠道组织中发挥作用。

10-oxo-12(Z)-Octadecenoic Acid 是一种具有抗炎活性的脂肪酸。

N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline 是一种有效的 ALK5 抑制剂，IC50 为 7nM。

Hydroxyzine Pamoate (Bobsule) 是一种组胺 H1 受体拮抗剂，可有效治疗慢性荨麻疹、皮炎和组胺介导的瘙痒。它可作为止吐剂和镇静剂，缓解焦虑和紧张。

Oxantel Pamoate (Oxantel embonate) 是驱虫剂，有效针对 Trichuris muris 和钩虫。

Pyrantel pamoate (Pyrantel embonate) 是一种四氢嘧啶光谱驱虫剂，是烟碱乙酰胆碱受体激动剂。它可引起寄生虫的痉挛性肌肉麻痹。它可研究胃肠道线虫感染。

2-Bromoacetamide (α-Bromoacetamide) 是一类新兴的不受管制的消毒副产物，在动物中显示出发育毒性，能使乙醇脱氢酶失活。

Pyrvinium pamoate (Pyrvinium embonate) 是一种古老的驱虫药，用于治疗蛲虫病，由于其在某些类型的癌症中抑制 Wnt β-catenin 通路，它作为抗癌药物再次引起人们的关注。

8-Bromoadenosine(8-溴膘苷)是一种腺苷衍生物，其中氨基上的氢原子被溴原子取代，可用于合成具有特定生物活性的核苷酸。8-Bromoadenosine在体外表现出多种生物活性，包括抑制线粒体膜电位、降低细胞质Ca²⁺水平以及干扰RNA和蛋白质的合成。

2-Thiopheneacetamide, α-[(2-bromoacetyl)(3-chloro-4-methoxyphenyl)amino]-N-(2-phenylethyl)- 在生命科学相关研究中具有广泛的应用。

Pasireotide pamoate is a stable cyclohexapeptide somatostatin mimic. Pasireotide pamoate exhibits antisecretory, antiproliferative, and proapoptotic activity.

Bromoacetamido-C2-PEG2-NH-Boc is a polyethylene glycol (PEG)-based linker with a bromoacetamido functional group and a tert-butoxycarbonyl (Boc) protecting group. It serves as an integral component in the synthesis of proteolysis-targeting chimeras (PROTACs), which are innovative compounds used for targeted protein degradation[1].

Bromoacetamido-PEG2-C2-acid is a polyethylene glycol (PEG)-based linker employed for PROTAC synthesis[1].

Bromoacetamido-PEG2-C2-NHS ester is a PEGylation-based linker compound utilized in PROTAC synthesis[1].

Bromoacetamido-PEG3-azide is a polyethylene glycol (PEG)-based linker used for the synthesis of proteolysis-targeting chimeras (PROTACs)[1].

Bromoacetamido-PEG3-C2-acid is a polyethylene glycol (PEG) derived linker for the synthesis of proteolysis targeting chimeras (PROTACs)[1].

Bromoacetamido-PEG3-C2-Boc is a polyethylene glycol (PEG) derived linker that is suitable for the synthesis of proteolysis-targeting chimeras (PROTACs) [1].

Bromoacetamido-PEG3-NH-Boc is a polyethylene glycol (PEG)-based linker compound employed in the synthesis of proteolysis-targeting chimeras (PROTACs)[1].

Bromoacetamido-PEG4-acid is a PEG-based PROTAC linker utilized for PROTAC synthesis[1]. It also serves as a cleavable 4-unit PEG ADC linker in the synthesis of antibody-drug conjugates (ADCs)[2].

Bromoacetamido-PEG4-C2-Boc is a polyethylene glycol (PEG)- and alkyl ether-based linker commonly employed for the synthesis of proteolysis targeting chimeras (PROTACs)[1].

Bromoacetamido-PEG4-NHS ester is a PEGylated N-hydroxysuccinimide ester compound, specifically designed as a linker for PROTAC synthesis. This PEG-based PROTAC linker, when utilized, facilitates the creation of protein-targeted chimeras (PROTACs)[1].

Bromoacetamido-PEG5-azide is a polyethylene glycol (PEG)-based linking molecule, commonly known as a PROTAC linker, which is utilized for the efficient synthesis of PROTACs[1].